1. Bares R (1990) Immunszintigraphie kolorektaler Tumoren: Probleme und Grenzen der Methode. Nuklearmediziner 3 /13: 173–181
2. Bares R, Fass J, Truong S et al. (1989) Radioimmunoscintigraphy with 111-In labeled monoclonal antibody fragments (F(ab)2 BW 431/31) against CEA: radiolabeling, antibody kinetics and distribution, findings in tumour and nontumour patients. Nucl Med Commun 10: 627–641
3. Baum RP, Lorenz M, Hottenrott C et al. (1988) The clinical application of immunoscintigraphy: results of a prospective study controlled by surgery, histology and immunochemistry and compared to CT-scan and sonography. In: Schmidt HAE, Csernay L (eds) Nuklearmedizin, neue Aspekte und Möglichkeiten. Schattauer, Stuttgart, pp 611–615
4. Becker N, Fentzel-Beyme R, Wagner G (1984) Krebsatlas der Bundesrepublik Deutschland, 2nd edn. Springer, Berlin Heidelberg New York
5. Bischof-Delaloye A, Delaloye B, Buchegger F et al. (1989) Clinical value of immunoscintigraphy in colorectal carcinoma patients: a prospective study. J Nucl Med 30: 1646–1656